483 Avista Pharma Solutions Nov 2018

483 Avista Pharma Solutions Nov 2018

Erika Butler FDA$119.00 - Available Now

FDA investigators audited the Avista Pharma Solutions - Longmont, CO, United States facility and issued inspectional observations (via FDA 483) on 09 Nov 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Nov 2018
  • Location: Longmont, United States
  • FEI: 3012316957
Add To Cart